Residual Solvents and Elemental Impurities: Classification & Exposure Limits as per ICH Q3C AND Q3D

  Рет қаралды 13,130

Pharma Growth Hub

Pharma Growth Hub

Күн бұрын

Пікірлер: 14
@suniladiyodi
@suniladiyodi 8 ай бұрын
Randomly came to this video for me yesterday and i watched the first 10 min. of it. Today i got a call for an interview & scheduled it in 1hr. One question was about the elemental impurity. You really saved me. Thanks
@abhishekjoshi9650
@abhishekjoshi9650 11 ай бұрын
Thank you very Much
@siddharthjaiswal54
@siddharthjaiswal54 3 ай бұрын
Explain very well
@tannaprasanthkumar2356
@tannaprasanthkumar2356 22 күн бұрын
Tnq sir nice voice
@QSEKCERTFSSAI
@QSEKCERTFSSAI 10 ай бұрын
🎉
@namratasawant390
@namratasawant390 Жыл бұрын
Nice video sir👍🏻
@omkarainapure9192
@omkarainapure9192 Жыл бұрын
Nice video sir. Please make video on XRD development and Validations
@AnkitYadav-lg9zs
@AnkitYadav-lg9zs 5 күн бұрын
Sir please make separate playlist for this
@IshaWaje
@IshaWaje 5 ай бұрын
Sir, what Abt API if it is use for topical application..
@sachinkakad777
@sachinkakad777 10 ай бұрын
If my product dose is less than 10gm and as per option 1 i am not meeting the acceptance criteria for solvent then in this case can i consider option 2?
@amsunasara
@amsunasara 2 күн бұрын
Yes, you can go for Option 2 even if your product dose is less than 10gm. Calculate the limit as per actual dose
@Dharshan.m-if4bn
@Dharshan.m-if4bn 9 ай бұрын
Hi, 1200 mg of content for nickel limit is 20 ppm is equal to 12 micro gram, but, you specified as 1.2 micro gram is wrong
@sambhajimasal4248
@sambhajimasal4248 Жыл бұрын
Sir, Thank you so much for this.,!!
@santhakumar2372
@santhakumar2372 Жыл бұрын
Component 1 is calculated as 1.2 ppm instead of 12
How to define limit for unknown, known and total impurities
26:07
Pharma Growth Hub
Рет қаралды 61 М.
VIP ACCESS
00:47
Natan por Aí
Рет қаралды 30 МЛН
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
01:01
DO$HIK
Рет қаралды 3,3 МЛН
We Attempted The Impossible 😱
00:54
Topper Guild
Рет қаралды 56 МЛН
She made herself an ear of corn from his marmalade candies🌽🌽🌽
00:38
Valja & Maxim Family
Рет қаралды 18 МЛН
Out Of Specification (OOS) Investigation Phase Ia & Phase Ib (MHRA)
24:36
Pharma Growth Hub
Рет қаралды 26 М.
3 common interview questions on Forced Degradation
21:14
Pharma Growth Hub
Рет қаралды 22 М.
How to define limit for residual solvents in drug product
21:43
Pharma Growth Hub
Рет қаралды 8 М.
What is Photostability and how to conduct it?
17:09
Pharma Growth Hub
Рет қаралды 9 М.
What is Method Validation? How to perform Method Validation?
31:27
Pharma Growth Hub
Рет қаралды 51 М.
What are the differences in method validation between ICH and ANVISA?
12:26
ICH guidelines Quality
12:46
Sai Sruthi
Рет қаралды 111 М.
VIP ACCESS
00:47
Natan por Aí
Рет қаралды 30 МЛН